Your browser doesn't support javascript.
loading
A Patient-derived Xenograft Model of Pancreatic Neuroendocrine Tumors Identifies Sapanisertib as a Possible New Treatment for Everolimus-resistant Tumors.
Chamberlain, Chester E; German, Michael S; Yang, Katherine; Wang, Jason; VanBrocklin, Henry; Regan, Melanie; Shokat, Kevan M; Ducker, Gregory S; Kim, Grace E; Hann, Byron; Donner, David B; Warren, Robert S; Venook, Alan P; Bergsland, Emily K; Lee, Danny; Wang, Yucheng; Nakakura, Eric K.
Afiliación
  • Chamberlain CE; Center for Regeneration Medicine, University of California, San Francisco, California. eric.nakakura@ucsf.edu chester.chamberlain@ucsf.edu.
  • German MS; Diabetes Center, University of California, San Francisco, California.
  • Yang K; Department of Medicine, University of California, San Francisco, California.
  • Wang J; Center for Regeneration Medicine, University of California, San Francisco, California.
  • VanBrocklin H; Diabetes Center, University of California, San Francisco, California.
  • Regan M; Department of Medicine, University of California, San Francisco, California.
  • Shokat KM; Center for Regeneration Medicine, University of California, San Francisco, California.
  • Ducker GS; Diabetes Center, University of California, San Francisco, California.
  • Kim GE; Department of Medicine, University of California, San Francisco, California.
  • Hann B; Center for Regeneration Medicine, University of California, San Francisco, California.
  • Donner DB; Diabetes Center, University of California, San Francisco, California.
  • Warren RS; Department of Medicine, University of California, San Francisco, California.
  • Venook AP; Department of Radiology and Biomedical Imaging, University of California, San Francisco, California.
  • Bergsland EK; Department of Radiology and Biomedical Imaging, University of California, San Francisco, California.
  • Lee D; Department of Cellular Molecular Pharmacology, University of California, San Francisco, California.
  • Wang Y; Department of Cellular Molecular Pharmacology, University of California, San Francisco, California.
  • Nakakura EK; Department of Pathology, University of California, San Francisco, California.
Mol Cancer Ther ; 17(12): 2702-2709, 2018 12.
Article en En | MEDLINE | ID: mdl-30254185
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Pirazoles / Pirimidinas / Benzoxazoles / Tumores Neuroendocrinos / Resistencia a Antineoplásicos / Ensayos Antitumor por Modelo de Xenoinjerto / Everolimus Límite: Animals / Humans Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Pirazoles / Pirimidinas / Benzoxazoles / Tumores Neuroendocrinos / Resistencia a Antineoplásicos / Ensayos Antitumor por Modelo de Xenoinjerto / Everolimus Límite: Animals / Humans Idioma: En Revista: Mol Cancer Ther Asunto de la revista: ANTINEOPLASICOS Año: 2018 Tipo del documento: Article